Envista Holdings Corporation (NVST) SEC Filings & Earnings Calls
EquiReason read 13 Envista Holdings Corporation SEC filings in the last 12 months. Latest: 8-K on 2026-09-17 — Envista announces 2026 Investor Day to provide strategy, growth initiatives, innovation priorities, and long-term financial objectives. No specific financial details disclosed..
Source: SEC EDGAR filings · figures as of 2026-07-03 · read by EquiReason
- Market cap
- 3.8B
- P/E TTM
- 40.7
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
19 Aug 20268-K · 5.02, 8.01CEO Paul Keel appointed Chairman; base salary increased $200K to $1.3M; special $10M equity award (RSUs + PSUs tied to 4-year TSR). CFO Eric Hammes received $1.5M PSU award. Retention-focused compensation changes.open
Risks flagged
No material risk; compensation changes are standard retention tools.
“align with stockholder interest in retaining Mr. Keel’s service” · word for word
5 Aug 20268-K · 2.02, 7.01Envista reports Q2 2026 core sales growth of 5.0%, adjusted EBITDA +28% to $108M, and raises FY2026 guidance for core sales, adjusted EBITDA, and adjusted EPS.earningsopen
Figures in the filing · each found in the filing text
| Sales · Q2-2026 | $731M | |
| Core Sales Growth · Q2-2026 | 5.0% | |
| GAAP Diluted EPS · Q2-2026 | $0.33 | |
| Adjusted Diluted EPS · Q2-2026 | $0.41 | +58% y/y |
| GAAP Net Income · Q2-2026 | $54M | |
| Adjusted EBITDA · Q2-2026 | $108M | +29% y/y |
| Adjusted EBITDA Margin · Q2-2026 | 14.7% | |
| Operating Cash Flow · Q2-2026 | $119M | +34% y/y |
| Free Cash Flow · Q2-2026 | $105M | +38% y/y |
| Share Repurchases · Q2-2026 | $59M |
Guidance
FY26 core sales growth raised to 3.5%-4.5% from 2%-4%; FY26 adjusted EBITDA growth raised to 11%-14% from 7%-13%; FY26 adjusted diluted EPS raised to $1.50-$1.55 from $1.35-$1.45; FY26 free cash flow conversion ~100% (unchanged)
Guidance raised across core sales, adjusted EBITDA, and adjusted EPS, reflecting strong first-half performance and continued momentum.
Risks flagged
Macro uncertainty could impact future demand.
“In the context of macro uncertainty” · word for word
Tariff and trade policy risks mentioned in forward-looking statements.
“developments and uncertainties in trade policies and regulations including tariffs or other impositions on imported goods” · word for word
5 Aug 202610-QQ2 2026 earnings: revenue +7.1%, net income +103.4%, strong margin expansion and tariff refund benefit.earningsopen
Figures in the filing · each found in the filing text
| Sales · Q2-2026 | $731M | +7% y/y |
| Net income · Q2-2026 | $54M | +103% y/y |
| Free cash flow · H1-2026 | $89M | |
| Operating cash flow · H1-2026 | $116M | +30% y/y |
Risks flagged
Tariff cost pressure
“Overall, we paid approximately $30 million in IEEPA related tariffs.” · word for word
Geopolitical conflict
“Geopolitical conflict and tensions...could have an adverse impact on our business.”
6 May 202610-QSales $706M (+14% y/y); Gross profit margin 55.3; Operating profit margin 8.9open
Figures in the filing · each found in the filing text
| Sales · Q1-2026 | $706M | +14% y/y |
| Gross profit margin · Q1-2026 | 55.3% | |
| Operating profit margin · Q1-2026 | 8.9% | |
| Net income · Q1-2026 | $39M | +115% y/y |
| Core sales growth · Q1-2026 | 9.5% | |
| Specialty Products & Technologies sales · Specialty Products & Technologies · Q1-2026 | $458M | +14% y/y |
| Equipment & Consumables sales · Equipment & Consumables · Q1-2026 | $248M | +14% y/y |
| Operating cash flow · Q1-2026 | $-3M | |
| Capital expenditures · Q1-2026 | $13M | +112% y/y |
Risks flagged
Tariff cost pressure
“we have already experienced an increase in cost of sales due to higher tariffs.” · word for word
China demand weakness
“partially offset by lower demand in China.” · word for word
Geopolitical conflict risk
“Geopolitical conflict and tensions, such as Russia’s invasion of Ukraine, the ongoing events in the Middle East, including the conflict involving Iran, and the global response to these conflicts...could have an adverse impact on our business” · word for word
6 May 20268-K · 2.02, 7.01Sales $706M; GAAP Net Income $39M; Adjusted EBITDA $99M (+25% y/y); Guidance: Core sales growth 2-4%; Adj. EBITDA growth 7-13%; Adj. EPS $1.35-$1.45earningsopen
Figures in the filing · each found in the filing text
| Sales · Q1-2026 | $706M | |
| GAAP Net Income · Q1-2026 | $39M | |
| Adjusted EBITDA · Q1-2026 | $99M | +25% y/y |
| Adjusted diluted EPS · Q1-2026 | $0.36 | +50% y/y |
Guidance
Core sales growth 2-4%; Adj. EBITDA growth 7-13%; Adj. EPS $1.35-$1.45
Reaffirms FY2026 guidance; strong Q1 with margin expansion and buyback authorization.
Risks flagged
Macro uncertainty and tariff risks
“In the context of macro uncertainty ... developments and uncertainties in trade policies and regulations including tariffs”
7 Apr 2026DEF 14AProxy statement filed for 2026 annual meeting, disclosing executive compensation, financial highlights, and governance practices.open
Figures in the filing · each found in the filing text
| Total Revenue · FY2025 | $2.72B | +8% y/y |
| Core Sales Growth · FY2025 | 6.5% | |
| Net Income (Loss) · FY2025 | $47M | |
| Adjusted EBITDA · FY2025 | $372M | +26% y/y |
| Adjusted EBITDA Margin · FY2025 | 13.7% | |
| Free Cash Flow · FY2025 | $231M | -24% y/y |
| Operating Cash Flow · FY2025 | $276M | -18% y/y |
| Adjusted Diluted EPS · FY2025 | $1.19 | +63% y/y |
Guidance
2026 ICP metrics changed: adjusted EBITDA margin replaced with adjusted EBITDA ($); 2026 LTI values increased for some NEOs
2025 performance shows strong demand recovery and margin expansion; 2026 compensation changes reflect continued focus on growth and profitability.
Risks flagged
2023-2025 PSU zero payout indicates historical underperformance
“The Compensation Committee determined that 0% vesting of the 2023-2025 PSUs was aligned with financial performance during the three-year performance period and did not approve any vesting of the 2023-2025 PSUs.” · word for word
Free cash flow declined 23.7% in 2025
“Free Cash Flow* $230.9 (2025) vs $302.8 (2024)”
12 Feb 202610-KInternational Sales Percentage 53; China Sales Percentage 7; Henry Schein Sales Percentage 12open
Figures in the filing · each found in the filing text
| International Sales Percentage · Consolidated · FY2025 | 53.0% | |
| China Sales Percentage · Consolidated · FY2025 | 7.0% | |
| Henry Schein Sales Percentage · Consolidated · FY2025 | 12.0% | |
| Total Debt · Consolidated · 2026-02-06 | $1.50B |
Risks flagged
Tariff Cost Pressure
“We have already experienced an increase in costs attributable to higher tariffs.” · word for word
China VBP Risk
“China has implemented volume-based procurement policies... that has resulted in significant price cuts for medical and dental consumable products.” · word for word
Customer Concentration
“Henry Schein, which accounted for approximately 12% of our sales in 2025” · word for word
High Leverage
“We have outstanding indebtedness of approximately $1.5 billion as of February 6, 2026” · word for word
Discretionary Spending Sensitivity
“certain products and services that support discretionary dental procedures may be susceptible to changes in economic conditions.” · word for word
5 Feb 20268-K · 2.02, 7.01Sales $751M; Core Sales Growth 10.8; GAAP Diluted EPS $0.20; Guidance: FY 2026 guidance: core sales growth 2-4%, adjusted EBITDA growth 7-13%, adjusted EPS $1.35-$1.45earningsopen
Figures in the filing · each found in the filing text
| Sales · consolidated · Q4-2025 | $751M | |
| Core Sales Growth · consolidated · Q4-2025 | 10.8% | |
| GAAP Diluted EPS · consolidated · Q4-2025 | $0.20 | |
| Adjusted Diluted EPS · consolidated · Q4-2025 | $0.38 | +58% y/y |
| GAAP Net Income · consolidated · Q4-2025 | $33M | |
| Adjusted EBITDA · consolidated · Q4-2025 | $111M | +22% y/y |
| Adjusted EBITDA Margin · consolidated · Q4-2025 | 14.8% | |
| Full Year Sales · consolidated · FY2025 | $2.72B | |
| Full Year Core Sales Growth · consolidated · FY2025 | 6.5% | |
| Full Year GAAP Diluted EPS · consolidated · FY2025 | $0.28 |
Guidance
FY 2026 guidance: core sales growth 2-4%, adjusted EBITDA growth 7-13%, adjusted EPS $1.35-$1.45
Initial 2026 guidance provided; Q4 and FY 2025 results exceeded expectations.
Risks flagged
Macro risks including inflation, interest rates, tariffs mentioned in forward-looking statements.
“Conditions in the U.S. and global economy, the impact of inflation and increasing interest rates, slower economic growth or recession.” · word for word
30 Oct 202510-QQ3 2025 earnings: revenue +11.5% YoY, core sales +9.4%, gross margin +250bps, operating profit +175% YoY; net loss due to tax charge.earningsopen
Figures in the filing · each found in the filing text
| Sales · Q3-2025 | $670M | +12% y/y |
| Gross Profit Margin · Q3-2025 | 55.3% | |
| Operating Profit · Q3-2025 | $58M | +175% y/y |
| Net Income (Loss) · Q3-2025 | $-30M | -470% y/y |
| Core Sales Growth (Non-GAAP) · Q3-2025 | 9.4% | |
| Specialty Products & Technologies Sales · Specialty Products & Technologies · Q3-2025 | $432M | +13% y/y |
| Equipment & Consumables Sales · Equipment & Consumables · Q3-2025 | $238M | +9% y/y |
| Operating Cash Flow · 9M-2025 | $168M | -18% y/y |
| Free Cash Flow · 9M-2025 | $139M | -23% y/y |
| Cash and Cash Equivalents · 2025-09-26 | $1.13B |
Risks flagged
Tariff cost pressure on margins
“While we expect to largely offset the impact of the existing tariffs with mitigating actions including supply chain adjustments, pricing strategies, and cost management, we have already experienced an increase in cost of sales attributable to higher tariffs.” · word for word
China demand weakness
“Geographically, sales for both the three and nine months ended September 26, 2025 were positively impacted by higher sales from North America and Europe; partially offset by lower demand in China.” · word for word
High effective tax rate volatility
“Our effective tax rate of 160.7% and 88.2% for the three and nine months ended September 26, 2025 differed from the comparable periods in 2024 primarily due to the impact of nondeductible impairment charges for goodwill and intangible assets in 2024 and primarily due to a change in the indefinite reinvestment assertion related to the restructuring of a forei” · word for word
Foreign exchange exposure
“Any future weakening of the U.S. dollar against major currencies would positively impact our sales and results of operations for the remainder of the year, and any strengthening of the U.S. dollar against major currencies would adversely impact our sales and results of operations for the remainder of the year.” · word for word
29 Oct 20258-K · 2.02, 7.01Sales $670M; Core Sales Growth 9.4; GAAP Diluted EPS $-0.18; Guidance: Core sales growth ~4% (from 3-4%), adjusted EPS $1.10-$1.15 (from $1.05-$1.15)earningsopen
Figures in the filing · each found in the filing text
| Sales · consolidated · Q3-2025 | $670M | |
| Core Sales Growth · consolidated · Q3-2025 | 9.4% | |
| GAAP Diluted EPS · consolidated · Q3-2025 | $-0.18 | |
| Adjusted Diluted EPS · consolidated · Q3-2025 | $0.32 | +167% y/y |
| GAAP Net Loss · consolidated · Q3-2025 | $-30M | |
| Adjusted EBITDA · consolidated · Q3-2025 | $97M | +76% y/y |
| Adjusted EBITDA Margin · consolidated · Q3-2025 | 14.5% | |
| YTD Sales · consolidated · 9M-2025 | $1.97B | |
| YTD Core Sales Growth · consolidated · 9M-2025 | 5.0% | |
| YTD GAAP Diluted EPS · consolidated · 9M-2025 | $0.08 |
Guidance
Core sales growth ~4% (from 3-4%), adjusted EPS $1.10-$1.15 (from $1.05-$1.15)
Raised full-year 2025 guidance; strong Q3 beat with 9.4% core growth and 540bps margin expansion.
Risks flagged
GAAP net loss due to tax charge from intercompany loan restructuring.
“GAAP Net Loss was $30 million, as a result of a tax charge from the restructuring of certain intercompany loans.” · word for word
Macro risks including inflation, interest rates, tariffs mentioned in forward-looking statements.
“Conditions in the U.S. and global economy, the impact of inflation and increasing interest rates, slower economic growth or recession.” · word for word
29 Oct 20258-K · 7.01Donated goods and services $2M; Safety incident rate reduction 13open
Figures in the filing · each found in the filing text
| Donated goods and services · FY2024 | $2M | |
| Safety incident rate reduction · FY2024 | 13.0% |
Risks flagged
No material risks disclosed; forward-looking statements are boilerplate.
“Standard forward-looking statements with no specific risk updates.”
Envista Holdings Corporation — questions
- What did Envista Holdings Corporation file recently?
- 13 SEC filings in the last 12 months. Latest: 8-K on 2026-09-17 — Envista announces 2026 Investor Day to provide strategy, growth initiatives, innovation priorities, and long-term financial objectives. No specific financial details disclosed.
Every figure on this page comes from Envista Holdings Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.